CSL
Diana Lanchoney

Diana Lanchoney

Vice President Clinical Development Operations at CSL

Diana Lanchoney is an experienced professional who has held various leadership roles in companies like CSL Behring and Merck. Diana has expertise in clinical development operations, R&D project management, clinical pharmacology, translational development, corporate strategy, new vaccine planning, vaccine ventures, strategic business development, and strategic integration in developing countries. Diana has a medical degree and a background in economics and German studies from University of Pennsylvania School of Medicine and Tufts University, respectively.

Links

Org chart

Manager

Bill Mezzanotte

EVP, Head of Research & Development & Chief Medical Officer

Peers

Debbie Bensen-Kennedy

Vice President Medical Affairs

Esther Heijnen

Vice President - Head Of Clinical Development Vaccines

Adrian Zuercher

Vice President, Head Of Research Europe And Head Of Plasma Protein Research

Reports

John Mallee

Principal Clinical Scientist

Alkesh Dudhaiya

Global Regulatory Lead - Medical Devices

Gail Berman

Senior Global Clinical Program Director

Ingo Pragst

Global Clinical Scientist Lead

Timeline

Vice President Clinical Development Operations
August, 2022 - present
Vice President, Clinical Pharmacology And Translational Development
January, 2018
Vice President, R&d Project Management
November, 2014

View in org chart